Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma
Author:
Funder
National Institutes of Health
Florida Department of Health
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference20 articles.
1. Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis;A Dubecz;J Thorac Oncol,2012
2. Esophageal cancer: staging system and guidelines for staging and treatment;MF Berry;J Thorac Dis,2014
3. Biomarkers of Barrett's Esophagus: From the Laboratory to Clinical Practice;VJA Konda;Dig Dis Sci,2018
4. Genetic clonal diversity predicts progression to esophageal adenocarcinoma;CC Maley;Nat Genet,2006
5. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation;G Clement;J Pathol,2006
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of Cytotoxic Activity of Epigenetic Drugs in Oesophageal Squamous Cell Carcinoma;European Journal of Medical and Health Sciences;2023-03-05
2. Therapeutic strategies for non-small cell lung cancer: Experimental models and emerging biomarkers to monitor drug efficacies;Pharmacology & Therapeutics;2023-02
3. A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer;Translational Oncology;2022-01
4. Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma;Cancers;2021-08-13
5. Recycling the Purpose of Old Drugs to Treat Ovarian Cancer;International Journal of Molecular Sciences;2020-10-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3